Notice: Doddington Lock and Islip Lock
Information on the closures/restrictions affecting the navigation. read more
Information on the closures/restrictions affecting the navigation. read more
Sixty seven projects will win a share of £26 million funding available through Biomedical Catalyst 2016, which is run by Innovate UK and the Medical Research Council, and aims to develop innovative healthcare technologies and processes.
For the first time, Scotland’s economic development agency Scottish Enterprise have also invested in projects. They have provided additional funding to seven Scottish companies, securing local support for nationally competitive innovations.
Glasgow-based SAW DX will create ‘ultrasonic holograms’ to diagnose sexually transmitted infections much quicker than the current tests allow.
The Native Antigen Company from Oxford are developing a quick and easy test for Zika virus, which differentiates the virus from Dengue Fever and hopes to provide reassurance to millions of mothers-to-be who live in tropical countries.
Cambridge based Cell Guidance Systems have developed a way to use protein from silk worms to heal cartilage and potentially reduce the need for joint replacement in people with osteoarthritis.
Micropharm, from Newcastle Emlyn in West Wales are using antibodies produced by sheep to develop a treatment for antibiotic resistant ’superbugs‘, such as Chlostridium difficle.
Supporting the announcements, Chief Executive of Innovate UK Dr Ruth McKernan said:
Our biosciences sector, supported by the Biomedical Catalyst, is a fantastic example of the UK’s joined-up innovation ecosystem in action. Our excellent researchers develop new and novel treatments and procedures that are then commercialised by our world-class businesses.
By becoming a co-funder in the Biomedical Catalyst, Scottish Enterprise will be helping to bring together Innovate UK’s national expertise in innovation with their own specific local priorities to boost local and national economic growth.
Sir John Savill, Chief Executive of the Medical Research Council said:
The Biomedical Catalyst is an important collaboration between the Medical Research Council and Innovate UK and we are pleased with the impressive results from the initiative to date. This unique partnership is clearly valued by both academia and industry – as evidenced by this latest investment from Scottish Enterprise.
Julia Brown, Director of Life and Chemical Sciences at Scottish Enterprise added:
We’re working hard to create more opportunities for Scottish businesses to secure business innovation funding. This first-of-its-kind partnership with Innovate UK and the Medical Research Council is just one way we’re achieving this, while integrating our support with our partners to generate more impact for the Scottish economy.
I’m pleased to see seven Scottish life science companies winning funding to support their innovative healthcare products, which demonstrates Scotland’s thriving life sciences industry and our long established reputation for creativity and business innovation.
The Biomedical Catalyst partnership between Innovate UK and the Medical Research Council has provided funding for 384 projects that have led to more than 60 first-in-human studies for innovative products. The programme has also helped bring more than £1 billion of additional investment into the UK bioscience sector.
In Autumn Statement 2016, the Chancellor Phillip Hammond announced £100 million of additional funding to extend and enhance the Biomedical Catalyst to support life science companies and translate cutting-edge medical technologies into commercial success.
read moreDrivers will shortly be able to use the new £192 million A556 Knutsford to Bowdon dual carriageway in Cheshire, with the final phase of work starting next month.
Highways England, which is building the new link road between junction 19 of the M6 at Knutsford and junction 7 of the M56 at Bowdon, today detailed the final phase of road works for the project – paving the way for the new road to open in March , providing a faster and more reliable link between the 2 motorways.
View looking north from new A50 bridge – with finishing landscaping and carriageway works underwayFull weekend closures – of the existing A556, junction 19 of the M6 and junctions 7 and 8 of the M56 – are needed and are scheduled to start in mid-February. The closures will allow the old road to be sealed off from through traffic and the motorway junctions to be tied into the new dual carriageway.
Highways England project manager Paul Hampson said:
View from new A50 bridge looking southWe are on course to open the new dual carriageway by the end of March, if not sooner. As well as starting work next month to connect the new dual carriageway to the M6 and M56 link roads, we’ll be using the weekend closures to do some preparation along the existing A556 which will become a B road with much-improved facilities for pedestrians and cyclists.
We’re working hard with partners and stakeholders like the emergency services and Manchester Airport to plan for these weekend closures and to make sure they’ll be well-publicised once the full details are confirmed.
Drivers are being advised the schedule for the final phase of work is dependent on the weather. The schedule currently involves:
Highways England is working with partners and stakeholders such as Manchester Airport, major football clubs and the police to plan for and publicise the road works so drivers can plan journeys affected by the weekend closures. More information and advice will be released nearer the time of the closures.
Alternative view looking north up the new A556Construction of the new A556 link road, between the M56 and the M6, started in November 2014 and is part of a £15 billion government investment in motorways and major A roads by 2021 which is being delivered by Highways England as part of the Northern Powerhouse initiative.
Members of the public should contact the Highways England customer contact centre on 0300 123 5000.
Journalists should contact the Highways England press office on 0844 693 1448 and use the menu to speak to the most appropriate press officer.
read moreFrom: First published: 25 January 2017 Part of: Public are encouraged to take part in a consultation for the A19 Testos junction improvement scheme. Local residents, businesses and road users are encouraged to take part in a 5 week statutor… read more
Remember to use our quick guides and training resources when working in the Client and Cost Management System (CCMS).
Our CCMS ‘quick guides’ and training modules are essential resources to help you work efficiently and avoid time-consuming calls to our customer service lines.
This is the first in a series of articles to help signpost you to the guidance and resources you need to work as efficiently as possible in CCMS.
Below are examples of ‘quick guides’ available to look at which deal with areas we regularly receive calls about:
Provider quick guides:
Managing live cases – see ‘Responding to a show cause’ and ‘Provider transfer’
Navigation in CCMS – see ‘Submitting electronic evidence’
Making an initial application – range of modules on ‘emergency’ applications